White House offers to talk to Minaj about vaccines
Reuters
Published Sep 15, 2021 09:21PM ET
Updated Sep 17, 2021 02:45AM ET
WASHINGTON (Reuters) - The White House is willing to set up a call for American rapper Nicki Minaj about the safety and effectiveness of the coronavirus vaccine after she said she wanted to do more research on vaccines before getting one.
"As we have with others, we offered a call with Nicki Minaj and one of our doctors to answer questions she has about the safety and effectiveness of the vaccine," said a White House official.
Minaj had said in a tweet that she had not been able to complete enough research of her own on the COVID-19 vaccines to get one in time for the Met Gala, a star-studded fundraiser for New York's Metropolitan Museum of Art.
Later, Minaj added that she will get vaccinated to be able to tour.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.